Dong-A ST Co., Ltd.
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1932-01-01
- Employees
- 1.6K
- Market Cap
- -
- Website
- http://www.donga-st.com
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
- First Posted Date
- 2021-03-15
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 2500
- Registration Number
- NCT04798690
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Seodaemun-gu, Korea, Republic of
Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 598
- Registration Number
- NCT04785326
- Locations
- 🇺🇸
Central Sooner Research, Norman, Oklahoma, United States
🇺🇸Jordan Valley Dermatology Center, West Jordan, Utah, United States
The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2020-12-29
- Last Posted Date
- 2021-05-26
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 29
- Registration Number
- NCT04686825
- Locations
- 🇰🇷
Seoul National University Hospital, Soeul, Korea, Republic of
Bioequivalence Study Between "DA-5209 Tab" and "Lixiana Tab"
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2021-02-09
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 121
- Registration Number
- NCT04671316
- Locations
- 🇰🇷
H Plus Yangji Hospital, Seoul, Korea, Republic of
A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg
- First Posted Date
- 2020-12-04
- Last Posted Date
- 2020-12-11
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT04653779
- Locations
- 🇰🇷
Suncheonhyang Bucheon Hospital, Bucheon, Gyeonggi, Korea, Republic of
🇰🇷Se-jong hospital, Bucheon, Gyeonggi, Korea, Republic of
Phase 1 Clinical Trial to Evaluate the Safety, PK and PD of DA-5207 TDS in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2021-04-15
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 49
- Registration Number
- NCT04479865
- Locations
- 🇰🇷
Severance Hospital Clinical Trial Center, Seoul, Korea, Republic of
Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2021-03-05
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT04473417
- Locations
- 🇰🇷
Bundangseoul national unversity hospital, Sŏngnam, GyeonggiDo, Korea, Republic of
Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
- Conditions
- Interventions
- First Posted Date
- 2020-04-22
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 198
- Registration Number
- NCT04356742
- Locations
- 🇰🇷
The Catholic University of Korea Bucheon St. Mary's Hospital, Bucheon, Korea, Republic of
Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.
- Conditions
- Interventions
- First Posted Date
- 2020-03-30
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 1971
- Registration Number
- NCT04326166
- Locations
- 🇰🇷
Sanggye paik pospital, Seoul, Nowon-gu, Korea, Republic of
Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab"
- Conditions
- Interventions
- First Posted Date
- 2020-03-27
- Last Posted Date
- 2020-03-27
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 56
- Registration Number
- NCT04325009
- Locations
- 🇰🇷
H Plus Yangji Hospital, Seoul, Korea, Republic of